Torrent Pharmaceuticals has confirmed that it, along with persons acting in concert (PAC), did not create any encumbrance on the shares of J B Chemicals & Pharmaceuticals Limited during the financial year ended March 31, 2026. This declaration ensures that the shares held by the acquirer remain free from charges such as pledges or hypothecation, providing clarity to shareholders regarding the status of the stake.

The disclosure was filed pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires acquirers to inform the stock exchanges if any encumbrance has been created on the shares of the target company during a financial year. The confirmation was submitted by Chintan M. Trivedi, Company Secretary of Torrent Pharmaceuticals Limited.

The notification was addressed to the Corporate Relationship Department of BSE Limited and the Listing Department of National Stock Exchange of India Limited. Copies of the declaration were also forwarded to the Company Secretary and the Audit Committee of J B Chemicals & Pharmaceuticals Limited for their records.

J B Chemicals & Pharmaceuticals Ltd announced the retirement of two senior management personnel effective June 30, 2026. Mr. Pradeep Kumar Singh, President Global Business, and Mr. Suresh Bhise, Vice President – IT, have retired from the services of the company. Consequently, they have ceased to be Senior Management Personnel with effect from the close of business hours on June 30, 2026.

The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification references the SEBI Master Circular bearing reference no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and No. CIR/CFD/CMD/4/2015 dated September 09, 2015.

The table below details the changes in the senior management personnel:

The filing was submitted by Sandeep Phadnis, Vice President – Secretarial & Company Secretary.